{
  "id": "lymphoma-resource-allocation-main",
  "display_name": "Lymphoma Resource Allocation",
  "cohort": "DLBCL and FL Patients, Resource Utilization Analysis (2024–2025)",
  "insight_type": "Resource Optimization",
  "summary": "Wide variation in supportive care utilization across lymphoma treatment sites. Site C exceeds benchmarks by 47%, representing $375,000/year in unnecessary resource utilization.",
  "chart": {
    "type": "bar",
    "unit": "site",
    "data": [
      { "name": "Site A", "value": 92, "gap": -8, "highlight": false },
      { "name": "Site B", "value": 104, "gap": 4, "highlight": false },
      { "name": "Site C", "value": 147, "gap": 47, "highlight": true },
      { "name": "Site D", "value": 85, "gap": -15, "highlight": false },
      { "name": "Site E", "value": 108, "gap": 8, "highlight": false }
    ],
    "benchmark": 100,
    "nccn_target": 90
  },
  "financial_impact": {
    "annual_opportunity": "$375,000/year",
    "math": "$375,000/year = 47% excess × 85 patients × $9,400 avg. supportive care cost"
  },
  "clinical_impact": {
    "description": "Optimizing resource allocation can maintain or improve clinical outcomes while reducing unnecessary utilization.",
    "metrics": [
      {
        "type": "Hosp",
        "value": "-35%",
        "description": "Potential reduction in hospitalization rates"
      },
      {
        "type": "LoS",
        "value": "-2.4 days",
        "description": "Reduced length of stay when hospitalization occurs"
      },
      {
        "type": "ED",
        "value": "-42%",
        "description": "Reduced emergency department utilization"
      },
      {
        "type": "AEs",
        "value": "-28%",
        "description": "Decrease in Grade 3-4 adverse events"
      },
      {
        "type": "QoL",
        "value": "+18%",
        "description": "Improved quality of life scores with optimized care"
      }
    ],
    "quantitative": "-35% hospitalizations"
  },
  "peer_comparison": {
    "description": "Top-performing lymphoma treatment centers maintain 82% resource utilization vs. benchmark while achieving equal or better outcomes, representing $520,000/year in potential savings vs. current practices.",
    "peer_benchmark": 82,
    "financial_impact": {
      "annual_opportunity": "$520,000/year",
      "math": "$520,000/year = 18% reduction from benchmark × 305 patients × $9,400 avg. cost"
    },
    "action_steps": [
      {
        "text": "Perform in-depth analysis of Site C utilization patterns",
        "icon": "chart-line"
      },
      {
        "text": "Implement cross-site best practice sharing program",
        "icon": "users"
      },
      {
        "text": "Develop standardized supportive care pathways",
        "icon": "document"
      },
      {
        "text": "Create resource utilization review committee",
        "icon": "clipboard"
      }
    ]
  },
  "weighted_score": 94,
  "action_steps": [
    {
      "text": "Analyze Site C resource utilization by care category",
      "icon": "chart-line"
    },
    {
      "text": "Implement standardized antiemetic protocols across all sites",
      "icon": "document"
    },
    {
      "text": "Develop G-CSF utilization guidelines based on Site D approach",
      "icon": "clipboard"
    },
    {
      "text": "Create automated alerts for resource-intensive orders",
      "icon": "alert"
    }
  ],
  "suggestions": [
    {
      "text": "Consider supportive care pharmacist integration at Site C",
      "icon": "users"
    },
    {
      "text": "Implement proactive symptom management program",
      "icon": "document"
    }
  ],
  "drilldowns": [
    {
      "label": "By Treatment Phase",
      "cohort": "Lymphoma Resource Utilization by Treatment Phase",
      "jsonFile": "lymphoma-resource-by-phase.json",
      "drilldownLevel": 1
    },
    {
      "label": "By Resource Category",
      "cohort": "Lymphoma Resource Utilization by Category",
      "jsonFile": "lymphoma-resource-by-category.json",
      "drilldownLevel": 1
    },
    {
      "label": "By Provider",
      "cohort": "Lymphoma Resource Utilization by Provider",
      "jsonFile": "lymphoma-resource-by-provider.json",
      "drilldownLevel": 1
    }
  ]
} 